The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression
Abstract
AIM: Brain-derived neurotrophic factor (BDNF) is associated with antidepressant response on the cellular level, in animal models, and in clinical studies. A common variant in the BDNF gene results in a substitution of a methionine (Met) for a valine at the amino acid position 66. Previous studies reported that the Met variant results in enhanced response to antidepressant medications. These findings may be at odds with studies indicating that on a cellular level the Met variant impairs the secretion of BDNF. MATERIALS AND METHODS: We examined the effects of BDNF single nucleotide polymorphisms (SNPs) in response to the antidepressants paroxetine and mirtazapine in a sample of 246 geriatric patients with major depression, treated in a double-blind, randomized, 8-week clinical trial. We also examined the effects of genetic variation at the BDNF-related loci neurotrophic tyrosine kinase receptor 2, cyclic AMP responsive element binding protein 1 (CREB1), and CREB binding protein. A total of 53 SNPs were genotyped. RESULTS: BDNF genetic variation had a significant effect on the efficacy of paroxetine, with patients carrying the Met allele showing impaired response. SNPs at the CREB1 locus, which encodes a transcription factor important in BDNF signaling, also predicted response to paroxetine. Furthermore, we found a significant gene-gene interaction between BDNF and CREB1 that affected response to paroxetine. Because BDNF has been associated with cognitive function, we tested the effects of BDNF SNPs on change in a wide variety of cognitive tests over the 8-week trial, but there were no significant effects of genotype on cognition. CONCLUSION: These results provide new evidence for the importance of the BDNF pathway in antidepressant response in geriatric patients. The negative effect of the Met66 allele on antidepressant outcomes is consistent with basic science findings indicating a negative effect of this variant on BDNF activity in the brain. Further, the effect of BDNF genetic variation on antidepressant treatment is modified by variation in the gene encoding the downstream effector CREB1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another study of individuals with LLD found that the Met allele predicted poorer response to paroxetine, and that this effect was moderated by the cyclic AMP responsive element binding protein 1 (CREB1)207.”
From Psychobiological factors of resilience and depression in late life (2019) · cites this paper as [207]
In the citing paper
“Another study of individuals with LLD found that the Met allele predicted poorer response to paroxetine, and that this effect was moderated by the cyclic AMP responsive element binding protein 1 (CREB1)207.”
From Psychobiological factors of resilience and depression in late life (2019) · cites this paper as [207]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
A second generation human haplotype map of over 3.1 million SNPs
The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109
Purification of a new neurotrophic factor from mammalian brain.
Barde, Y. A., Edgar, D., & Thoenen, H. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01207.x · Cited by 1,822
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior
Chen, Z.-Y., Jing, D., Bath, K. G., Ieraci, A., Khan, T., Siao, C.-J., Herrera, D. G., Toth, M., Yang, C., McEwen, B. S., et al. (2006) · Science · doi:10.1126/science.1129663 · Cited by 1,340
Hariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., Egan, M. F., & Weinberger, D. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06690.2003 · Cited by 1,045
Cited by
Amare, A. T., Schubert, K. O., Klingler-Hoffmann, M., Cohen-Woods, S., & Baune, B. T. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.261 · Cited by 345
Psychobiological factors of resilience and depression in late life
Laird, K. T., Krause, B., Funes, C., & Lavretsky, H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0424-7 · Cited by 229
Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network
Bush, W., Crosslin, D., Owusu‐Obeng, A., Wallace, J., Almoguera, B., Basford, M., Bielinski, S., Carrell, D., Connolly, J., Crawford, D., et al. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.350 · Cited by 182
Epigenetic alterations in depression and antidepressant treatment
Menke, A., & Binder, E. B. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.3/amenke · Cited by 161
Predictors of treatment outcome in depression in later life: A systematic review and meta-analysis
Tunvirachaisakul, C., Gould, R. L., Coulson, M., Ward, E. V., Reynolds, G., Gathercole, R. L., Grocott, H., Supasitthumrong, T., Tunvirachaisakul, A., Kimona, K., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.10.008 · Cited by 128
Blood biomarkers and treatment response in major depression
Mora, C., Zonca, V., Riva, M. A., & Cattaneo, A. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1470927 · Cited by 107
Jin, H., Pei, L., Li, Y., Zheng, H. W., Yang, S., Wan, Y., Mao, L., Xia, Y., He, Q., Li, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13929-5 · Cited by 102
Genetic variants in major depressive disorder: From pathophysiology to therapy
Gonda, X., Petschner, P., Eszlári, N., Baksa, D., Édes, A. E., Antal, P., Juhász, G., & Bagdy, G. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.09.002 · Cited by 101
Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications
Fabbri, C., & Serretti, A. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0594-9 · Cited by 84
Advances in Biomarkers of Major Depressive Disorder
Huang, T., & Lin, C.-C. (2015) · Advances in clinical chemistry · doi:10.1016/bs.acc.2014.11.003 · Cited by 76
Are there meaningful biomarkers of treatment response for depression?
Breitenstein, B., Scheuer, S., & Holsboer, F. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.02.002 · Cited by 73
New insights into the genetics of fibromyalgia
Park, D.-J., & Lee, S. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.207 · Cited by 69
Zelada, M. I., Garrido, V., Liberona, A., Jones, N., Zúñiga, K., Silva, H., & Nieto, R. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914810 · Cited by 60
Kahl, K. G., Stapel, B., & Frieling, H. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.09.004 · Cited by 47
Antidepressant pharmacogenetics
Singh, A., Bousman, C., Ng, C. H., & Berk, M. (2013) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000023 · Cited by 47
Marshe, V. S., Islam, F., Maciukiewicz, M., Bousman, C., Eyre, H. A., Lavretsky, H., Mulsant, B. H., Reynolds, C. F., Lenze, E. J., & Müller, D. J. (2020) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.01.007 · Cited by 42
Blood-based biomarkers predicting response to antidepressants
Busch, Y., & Menke, A. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1844-x · Cited by 37
Yasuda, S., Yoshida, M., Yamagata, H., Iwanaga, Y., Suenaga, H., Ishikawa, K., Nakano, M., Okuyama, S., Furukawa, Y., Furukawa, S., et al. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0097-y · Cited by 34
Neurotropin® Ameliorates Chronic Pain via Induction of Brain-Derived Neurotrophic Factor
Ishikawa, T., Yasuda, S., Minoda, S., Ibuki, T., Fukuhara, K., Iwanaga, Y., Ariyoshi, T., & Sasaki, H. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0118-x · Cited by 31
Wagner, S., Kayser, S., Engelmann, J., Schlicht, K. F., Dreimüller, N., Tüscher, O., Müller‐Dahlhaus, F., Braus, D. F., Tadić, A., Neyazi, A., et al. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1425478 · Cited by 32
Gene expression: Biomarker of antidepressant therapy?
Menke, A. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.825580 · Cited by 28
Matsumoto, Y., Fabbri, C., Pellegrini, S., Porcelli, S., Politi, P., Bellino, S., Iofrida, C., Mariotti, V., Melissari, E., Menchetti, M., et al. (2014) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-014-0110-7 · Cited by 25
Fabbri, C., Crisafulli, C., Calati, R., Albani, D., Forloni, G., Calabrò, M., Martines, R., Kasper, S. F., Zohar, J., Juven‐Wetzler, A., et al. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0766-1 · Cited by 25
Han, X., Wen, X., Wang, Y., Wang, S., Shen, M., Zhang, Z.-F., Fan, S., Shan, Q., Wang, L. Y., Li, M., et al. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0020-y · Cited by 25
RetractedLevchenko, А., Vyalova, N. M., Nurgaliev, T., Pozhidaev, I. V., Simutkin, G. G., Bokhan, N. A., & Ivanova, S. А. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00936 · Cited by 26
Eyre, H. A., Eskin, A., Nelson, S. F., Cyr, N. S., Siddarth, P., Baune, B. T., & Lavretsky, H. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4356 · Cited by 22
Neurobiological effects of phospholipids in vitro: Relevance to stress-related disorders
Donoso, F., Schverer, M., Rea, K., Pusceddu, M. M., Roy, B. L., Dinan, T. G., Cryan, J. F., & Schellekens, H. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100252 · Cited by 21
Lett, T. A. P., Walter, H., & Brandl, E. J. (2016) · CNS Drugs · doi:10.1007/s40263-016-0385-9 · Cited by 21
Li, S., Ma, H., Yuan, X., Zhou, X., Wan, Y., & Chen, S. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s243920 · Cited by 18
Understanding the pharmacogenetics of selective serotonin reuptake inhibitors
Fabbri, C., Minarini, A., Niitsu, T., & Serretti, A. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.928693 · Cited by 14
Xin, J., Yuan, M., Peng, Y., & Wang, J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00151 · Cited by 14
Wang, Y., Li, S., Niu, L., Ma, Y., Qiu, Y., Li, S., Guobule, N., Cao, H., & Li, J. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02415-y · Cited by 14
Wang, Q., Wang, H., & Dwivedi, Y. (2024) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2024.100365 · Cited by 7
Tsapekos, D., Kalfas, M., Schandorff, J. M., Bonnín, C. D. M., Bowie, C. R., Balanzá‐Martínez, V., Burdick, K. E., Carvalho, A. F., Dols, A., Douglas, K. M., et al. (2025) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.70038 · Cited by 6
Inoue, K., Murofushi, T., Nagaoka, K., Ando, N., Hakamata, Y., Suzuki, A., Umemura, A., Yoshida, Y., Hirai, K., Tsuji, D., et al. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00298 · Cited by 5
Molecular Network-Selected Pharmacogenomics in a Case of Bipolar Spectrum Disorder
Fortinguerra, S., Buriani, A., Sorrenti, V., Lenzi, M., & Giusti, P. (2017) · Pharmacogenomics · doi:10.2217/pgs-2017-0133 · Cited by 4
Pharmacogenomics in Psychiatric Disorders
Lam, Y. W. F., & Someya, T. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812626-4.00007-3 · Cited by 5
Fugger, G., Bartova, L., Fabbri, C., Fanelli, G., Zanardi, R., Dold, M., Kautzky, A., Rujescu, D., Souery, D., Mendlewicz, J., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.06.004 · Cited by 4
Kalueff, A. V., Stewart, A., Nguyen, M., Song, C., & Gottesman, I. I. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.05.004 · Cited by 4
Effect of desipramine on gene expression in the mouse frontal cortex – Microarray study
Solich, J., Kolasa, M., Kuśmider, M., Faron‐Górecka, A., Pabian, P., Szafran‐Pilch, K., Żurawek, D., & Dziedzicka‐Wasylewska, M. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.09.001 · Cited by 4
Depression in Older Adults: A Palliative Medicine Perspective
Jordan, A. E., Malhotra, S., Maree, R. D., Schenker, Y., Arnold, R. M., & Reynolds, C. F. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000069 · Cited by 5
Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies
Khokhlov, L. K., & Lukyanov, N. E. (2019) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2019-4.2.5 · Cited by 4
Higgins, G. A., Handelman, S. A., Allyn-Feuer, A., Ade, A. S., Burns, J. S., Omenn, G. S., & Athey, B. D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.28.053587 · Cited by 3
Dølven, S., Moroń, M., Eriksen, I., Toft, J. E. G., & Semkovska, M. (2025) · Neuropsychology Review · doi:10.1007/s11065-025-09686-2 · Cited by 2
Genetic Factors Underlying Treatment Resistance in Psychiatry
Maron, E., Lan, C., & Nutt, D. (2018) · Springer eBooks · doi:10.1007/978-981-10-4358-1_3 · Cited by 2
Complementation of Pharmacogenetics with Biomarkers and Neuroimaging in Major Depression
Menke, A., Dusi, N., & Brambilla, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-27040-1_5
Genetic Overlap Between Depression and Cardiometabolic Disorders
Amare, A. T., Schubert, K. O., & Baune, B. T. (2016) · Springer eBooks · doi:10.1007/978-3-319-32480-7_15
İleri Yaş Depresyonunda Farmakogenetik Yaklaşımlar
Özbey, G., ÖZKOÇ, C., ÖZKAN, Y. E., & SAKA, K. K. (2021) · Akdeniz Medical Journal · doi:10.53394/akd.957675
Sulliman, N. C., Verstuyft, C., Chappell, K., Becquemont, L., Corruble, E., & Colle, R. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117065 · Cited by 1
Metadata
- Authors
- Murphy, G. M., Sarginson, J. E., Ryan, H. S., O’Hara, R., Schatzberg, A. F., & Lazzeroni, L. C.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Murphy, Greer M.
- Venue
- Pharmacogenetics and Genomics
- Published
- 2013-06
- Volume
- 23
- Issue
- 6
- Pages
- 301-313
- ISSN
- 1744-6872 (ISSN-L)
- OpenAlex
- W2056261919
- Cited by
- 50
- References
- 56
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 6 · 2019: 3 · 2018: 7 · 2017: 7 · 2016: 5 · 2015: 5 · 2014: 7 · 2013: 2
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacogenetics and Genomics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R01MH073914, MH-47573, R01MH050604, MH073914-04S1, MH073914, MH50604, R01MH086135, R01MH047573)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- brain-derived neurotrophic factor, CREB1, geriatric depression, major depressive disorder, antidepressant response, paroxetine, mirtazapine, gene-gene interaction, single nucleotide polymorphisms, CREB-binding protein, cognitive function, pharmacogenetics
- MeSH terms
- Aged, Alleles, Antidepressive Agents, Depression, Female, Gene Frequency, Haplotypes, Humans, Male, Models, Genetic, Linkage Disequilibrium, Likelihood Functions, Treatment Outcome, Cyclic AMP Response Element-Binding Protein, Brain-Derived Neurotrophic Factor, Polymorphism, Single Nucleotide, Principal Component Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.